by Karolinska Institutet Credit: Pixabay/CC0 Public Domain Researchers at Karolinska Institutet are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers now hope to be able to take it to...
by University of Queensland A vaccine patch. Credit: The University of Queensland A needle-free vaccine patch could better fight COVID-19 variants, such as Omicron and Delta, than a traditional needle vaccine according to a University of Queensland study in mice. The research, conducted in partnership with Brisbane biotechnology company Vaxxas, tested the Hexapro SARS-CoV-2 spike vaccine using...
A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing. SK bioscience, the company leading the vaccine’s clinical development, will seek authorization for its use in South Korea within the month. The Seattle scientists behind the new vaccine sought to create a ‘second-generation’ vaccine for COVID-19...
For the study, researchers focused on all studies describing the response of patients with inflammatory bowel disease (IBD) who received a COVID-19 vaccine. People with the disease are commonly treated with drugs that suppress the immune system and have reported concerns over whether such treatments might weaken their response to the vaccine. “We wanted to demonstrate in...
by Massachusetts Institute of Technology Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH While many people in wealthier countries have been vaccinated against COVID-19, there...
by Bob Yirka, Science X Network, Medical Xpress Credit: Pixabay/CC0 Public Domain A team of researchers working at Israel’s Sheba Medical Center has found evidence that suggests a fourth COVID vaccination or second booster shot may not be necessary for most people because it does not add significant protection. In their paper posted on the...
by University of Birmingham Immune reconstitution following CD20 depletion and vaccine responsiveness. (A) Time between last administration of anti-CD20 B-cell-depleting treatment and vaccine administration (left panel—haemato-oncology patients [red], right panel—rheumatology patients [blue]). (B) Seropositivity following SARS-CoV-2 vaccination with respect to time from last administration of anti-CD20 B-cell depletion. (C) Association between the magnitude of antibody...
By Rich Haridy January 03, 2022 The initial Corbevax vaccine research was led by Maria Elena Bottazzi and Peter Hotez from the Texas Children’s Hospital Center for Vaccine DevelopmentTexas Children’s Hospital A new COVID-19 vaccine, developed by researchers from the Texas Children’s Hospital and Baylor College of Medicine, is being offered patent-free to vaccine manufacturers...
by Tiare Dunlap, University of California, Los Angeles Microscope image showing a human cell (pink) heavily infected with SARS-CoV-2 virus particles (green and purple). Credit: NIAID/NIH Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting...
by Nathan Bartlett, The Conversation Credit: Pixabay/CC0 Public Domain Last week, AstraZeneca’s chief executive officer said the company’s COVID vaccine may provide longer-lasting protection than mRNA vaccines like Pfizer’s, especially in older people. CEO Pascal Soriot said this might explain the United Kingdom’s more stable hospitalization rate compared to the escalating COVID situation in continental Europe. The UK...
